Effect of TTN Mutations on Immune Microenvironment and Efficacy of Immunotherapy in Lung Adenocarcinoma Patients

Immune checkpoint inhibitors (ICIs) effectively treat lung adenocarcinoma (LUAD) with fewer side effects. However, for LUAD patients, the lack of predictive markers for ICIs makes their clinical benefits less than ideal. Despite reports suggesting that a TTN (titin) mutation plays an important role...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhe, Wang, Chunguang, Lin, Shengcheng, Yu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426356/
https://www.ncbi.nlm.nih.gov/pubmed/34513703
http://dx.doi.org/10.3389/fonc.2021.725292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426356/
https://www.ncbi.nlm.nih.gov/pubmed/34513703
http://dx.doi.org/10.3389/fonc.2021.725292

Ejemplares similares